异动解读 | 分析师下调目标价,Avalo Therapeutics盘中大跌5.11%

异动解读
May 15

Avalo Therapeutics Inc(AVTX)今日盘中股价大幅下挫5.11%,引起了投资者的关注。

消息面上,多家华尔街投行在今日发布了针对该公司的研究报告并调整了其目标价,其中H.C. Wainwright将目标价从40美元下调至35美元,Wedbush将目标价从40美元下调至34美元,这两项关键的下调操作可能影响了市场信心,成为股价下跌的主要压力。

尽管瑞穗证券将目标价从39美元上调至45美元,但整体上分析师意见出现分歧,且下调目标价的行动对市场情绪产生了更直接的影响,导致该股在交易时段内承压走低。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10